Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Baby Box Technology for Sick Newborns Licensed to Start-Up

Newborn in incubator

A start-up company is gaining the rights to a technology that helps the breathing of infants suffering from withdrawal from drugs taken by their mothers, and other disruptive conditions. . . . → Read More: Baby Box Technology for Sick Newborns Licensed to Start-Up

Trial Testing Cancer Treatment Delivery Compound

Erkki Ruoslahti

A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer. . . . → Read More: Trial Testing Cancer Treatment Delivery Compound

FDA Clears Magnetic Device for Obsessive Compulsive Disorder

brain stimulationgraphic

A non-invasive device using magnetic waves that penetrate the brain to treat obsessive-compulsive disorder received authorization for sales in the U.S. from the Food and Drug Administration. . . . → Read More: FDA Clears Magnetic Device for Obsessive Compulsive Disorder

Genomic Sequencing for Newborns Studied in Clinical Trial

Newborn

A group of newborn infants with genetic disorders that went undetected in standard testing will receive genomic sequencing in a clinical study of its safety and feasibility. . . . → Read More: Genomic Sequencing for Newborns Studied in Clinical Trial

Low-Dose Triple Pill Reduces Blood Pressure in More People

3 generic capsules

A clinical trial shows a single medication with low doses of three common drugs reduces high blood pressure in more people with the condition than the normal care. . . . → Read More: Low-Dose Triple Pill Reduces Blood Pressure in More People

FDA Clears Fertility Awareness App for Birth Control

Natural Cycles app and device

A mobile app for determining a woman’s fertility state on any given day was cleared for marketing in the U.S. as a birth control method. . . . → Read More: FDA Clears Fertility Awareness App for Birth Control

FDA Approves RNA-Interference Nerve Disease Therapy

Onpattro

A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration. . . . → Read More: FDA Approves RNA-Interference Nerve Disease Therapy

Google Glass System Assessed for Autism Therapy

Autism study participant

A pilot study evaluating an autism spectrum disorder therapy that combines Google Glass with a smartphone app using machine learning shows a decrease in autism-related behaviors among the children in the test. . . . → Read More: Google Glass System Assessed for Autism Therapy

Trial Shows Antibiotic More Effective Against Crohn’s Disease

Cattle

Early results from a clinical trial show an experimental antibiotic drug helps more people achieve remission of their Crohn’s disease for longer periods than a similar group given a placebo. . . . → Read More: Trial Shows Antibiotic More Effective Against Crohn’s Disease

Technique Assessed for Comparing Effectiveness Between Drugs

Analytics

An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials. . . . → Read More: Technique Assessed for Comparing Effectiveness Between Drugs